Ogulur I, Mitamura Y, Yazici D, Pat Y, Ardicli S, Li M
Cell Mol Immunol. 2025; 22(3):211-242.
PMID: 39962262
PMC: 11868591.
DOI: 10.1038/s41423-025-01261-2.
Shrewsbury J, Vitus E, Koziol A, Nenarokova A, Jess T, Elmahdi R
J Virol. 2024; 98(11):e0110224.
PMID: 39431820
PMC: 11575288.
DOI: 10.1128/jvi.01102-24.
Rabin R
Curr Allergy Asthma Rep. 2024; 24(9):471-475.
PMID: 39046600
PMC: 11364621.
DOI: 10.1007/s11882-024-01168-4.
Rahman R, Wesemann D
Immunol Rev. 2024; 326(1):48-65.
PMID: 39041740
PMC: 11436312.
DOI: 10.1111/imr.13373.
Furiness K, El Ansari Y, Oettgen H, Kanagaratham C
Front Allergy. 2024; 5:1389669.
PMID: 38919913
PMC: 11196826.
DOI: 10.3389/falgy.2024.1389669.
Neutralizing IgG antibodies are a biomarker of sustained efficacy after peanut oral immunotherapy.
Keswani T, LaHood N, Marini-Rapoport O, Karmakar B, Andrieux L, Reese B
J Allergy Clin Immunol. 2024; 153(6):1611-1620.e7.
PMID: 38460677
PMC: 11894811.
DOI: 10.1016/j.jaci.2024.02.017.
Self-Assembling Allergen Vaccine Platform Raises Therapeutic Allergen-Specific IgG Responses without Induction of Systemic Allergic Responses.
Cossette B, Shetty S, Issah L, Collier J
ACS Biomater Sci Eng. 2024; 10(3):1819-1829.
PMID: 38366973
PMC: 11382287.
DOI: 10.1021/acsbiomaterials.3c01945.
Low-dose oral immunotherapy in immunoglobulin E-mediated food allergies.
Ma D, Zhu R
Front Immunol. 2024; 15:1321863.
PMID: 38361918
PMC: 10867954.
DOI: 10.3389/fimmu.2024.1321863.
Defining the cross-reactivity between peanut allergens Ara h 2 and Ara h 6 using monoclonal antibodies.
Marini-Rapoport O, Fernandez-Quintero M, Keswani T, Zong G, Shim J, Pedersen L
Clin Exp Immunol. 2024; 216(1):25-35.
PMID: 38346116
PMC: 10929694.
DOI: 10.1093/cei/uxae005.
Exploratory immunogenicity outcomes of peanut oral immunotherapy: Findings from the PALISADE trial.
Nilsson C, Vereda A, Borres M, Andersson M, Sodergren E, Rudengren M
Clin Transl Allergy. 2024; 14(1):e12326.
PMID: 38282192
PMC: 10793676.
DOI: 10.1002/clt2.12326.
Precision engineering for localization, validation, and modification of allergenic epitopes.
Pomes A, Smith S, Chruszcz M, Mueller G, Brackett N, Chapman M
J Allergy Clin Immunol. 2024; 153(3):560-571.
PMID: 38181840
PMC: 10939758.
DOI: 10.1016/j.jaci.2023.12.017.
IgE and IgG4 epitopes of the peanut allergens shift following oral immunotherapy.
Rambo I, Kronfel C, Rivers A, Swientoniewski L, McBride J, Cheng H
Front Allergy. 2023; 4:1279290.
PMID: 38093814
PMC: 10717846.
DOI: 10.3389/falgy.2023.1279290.
Applications of VirScan to broad serological profiling of bat reservoirs for emerging zoonoses.
Ruhs E, Chia W, Foo R, Peel A, Li Y, Larman H
Front Public Health. 2023; 11:1212018.
PMID: 37808979
PMC: 10559906.
DOI: 10.3389/fpubh.2023.1212018.
The origins and longevity of IgE responses as indicated by serological and cellular studies in mice and humans.
Ding Z, Mulder J, Robinson M
Allergy. 2023; 78(12):3103-3117.
PMID: 37417548
PMC: 10952832.
DOI: 10.1111/all.15799.
Advances and potential of omics studies for understanding the development of food allergy.
Sindher S, Chin A, Aghaeepour N, Prince L, Maecker H, Shaw G
Front Allergy. 2023; 4:1149008.
PMID: 37034151
PMC: 10080041.
DOI: 10.3389/falgy.2023.1149008.
IgG:FcγRIIb signals block effector programs of IgE:FcεRI-activated mast cells but spare survival pathways.
Kanagaratham C, Derakhshan T, El Ansari Y, Furiness K, Hollers E, Keldsen M
J Allergy Clin Immunol. 2023; 152(2):453-468.
PMID: 37030590
PMC: 10524869.
DOI: 10.1016/j.jaci.2023.03.027.
Germline-encoded amino acid-binding motifs drive immunodominant public antibody responses.
Shrock E, Timms R, Kula T, Mena E, West Jr A, Guo R
Science. 2023; 380(6640):eadc9498.
PMID: 37023193
PMC: 10273302.
DOI: 10.1126/science.adc9498.
Research Advances in Mast Cell Biology and Their Translation Into Novel Therapies for Anaphylaxis.
Dispenza M, Metcalfe D, Olivera A
J Allergy Clin Immunol Pract. 2023; 11(7):2032-2042.
PMID: 36958519
PMC: 10330051.
DOI: 10.1016/j.jaip.2023.03.015.
Immunotherapy-induced neutralizing antibodies disrupt allergen binding and sustain allergen tolerance in peanut allergy.
LaHood N, Min J, Keswani T, Richardson C, Amoako K, Zhou J
J Clin Invest. 2023; 133(2).
PMID: 36647835
PMC: 9843057.
DOI: 10.1172/JCI164501.
Human Monoclonal IgE Antibodies-a Major Milestone in Allergy.
Smith S, Chruszcz M, Chapman M, Pomes A
Curr Allergy Asthma Rep. 2022; 23(1):53-65.
PMID: 36459330
PMC: 9831959.
DOI: 10.1007/s11882-022-01055-w.